PSG’s PBM Customer Satisfaction Report provides the most in-depth picture of the PBM landscape today, leveraging perspectives taken directly from employer and health plan…
Who would have imagined one of the hottest online trends would be pharmaceuticals for weight loss? Social media and commercials are flooded with advertisements…
(DALLAS, TX) – Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the release of its annual Trends in Specialty Drug Benefits report. Delivering…
The pharmacy benefit management landscape is complex and ever-changing. With many new high-cost trending therapies currently available in addition to those on the horizon,…
Key Metrics: 7% of PBM claims processed incorrectly $600K of reimbursement dollars due to client Background When a large government organization discovered that their…
On March 15th the Centers for Medicare and Medicaid Services (CMS) released initial guidance on the Medicare Drug Price Negotiation Program (or “Negotiation…
Key Metrics: $5B amount saved by PSG’s RFP procurement clients in just one year. Background When planning their annual budget, a national retail employer…
Today is a milestone in the world of biosimilars, as the first Humira® biosimilar Amjevita™ (adalimumab-atto), manufactured by Amgen, has launched in the U.S. Will it…
Revolutionary Drug Management Reporting Tool Offers Powerful User Insights Dallas, TX (January 23, 2023) – Artemetrx®, the industry’s most preeminent platform for integrated drug cost…
Republished with Permission from AIS Health The FDA recently approved the first novel long-acting granulocyte colony-stimulating factor (G-CSF) in more…
